SK Biopharmaceuticals. (326030.KQ) Q4 2025 Earnings

5NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
191.99
900.52
1,609.04
2,317.56

Details

Expected EPS
349.0817791632
Actual EPS
928.9615973328
Surprise EPS
579.88
Surprise Percent
+166.12%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 928.9615973328 per share for Q4 2025.

0 Comments

Share your thoughts